Patricia van Dijck
Public Communications Contact presso GSK Belux
Profilo
Patricia van Dijck is currently the Director-Market Access & Public Affairs at GSK Belux since 2018.
Prior to this, she worked as an Independent Director at Mithra Pharmaceuticals SA from 2021 to 2023, as a Medical Director at Lundbeck SA from 1998 to 2007, and as the Head-Market Access & Public Affairs at Novartis Belux.
She holds a doctorate degree from the Université Catholique de Louvain.
Posizioni attive di Patricia van Dijck
| Società | Posizione | Inizio |
|---|---|---|
| GSK Belux | Public Communications Contact | 01/01/2018 |
Precedenti posizioni note di Patricia van Dijck
| Società | Posizione | Fine |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Presidente | 01/06/2021 |
| Novartis Belux | Public Communications Contact | - |
Lundbeck SA
 Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Amministratore Delegato | - |
Formazione di Patricia van Dijck
| Université Catholique de Louvain | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MITHRA PHARMACEUTICALS S.A. | Health Technology |
| Aziende private | 3 |
|---|---|
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Health Technology |
| Novartis Belux | |
| GSK Belux |
- Borsa valori
- Insiders
- Patricia van Dijck
